Clinical Trial Update: Tislelizumab in Combination With TACE in Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial exploring tislelizumab in combination with TACE for advanced hepatocellular carcinoma is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Zhongda Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN